IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 26 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,047 | -38.2% | 1,665 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $4,928 | +6.9% | 1,665 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,612 | -46.8% | 1,665 | 0.0% | 0.00% | -66.7% |
| Q4 2022 | $8,675 | +30.6% | 1,665 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $6,643 | +5.0% | 1,665 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,327 | -26.1% | 1,665 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $8,558 | -4.1% | 1,665 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $8,924 | -13.8% | 1,665 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $10,356 | +3.3% | 1,665 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $10,023 | – | 1,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 398,145 | $2,397,000 | 0.24% |
| INGALLS & SNYDER LLC | 600,810 | $3,617,000 | 0.16% |
| Ikarian Capital, LLC | 150,000 | $903,000 | 0.07% |
| Gradient Capital Advisors, LLC | 21,718 | $131,000 | 0.06% |
| WEST PACES ADVISORS INC. | 1,665 | $10,023 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,115 | $103,000 | 0.00% |
| Orion Portfolio Solutions, LLC | 14,111 | $85,000 | 0.00% |
| MARSHALL WACE, LLP | 36,259 | $218,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 12,538 | $75,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 88 | $1,000 | 0.00% |